Drug intelligence / Profile preview

gormode

Development stage: Preclinical
Lead developer: Tianjin Municipal Science and Technology Commission

Overview

Gormode is an investigational drug being studied for its immunomodulatory effects in the treatment of intracerebral hemorrhage (ICH). It is being developed by Tianjin Science and Technology Commission and Tianjin Third Central Hospital.

Beyond the preview

Go deeper on gormode.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on gormode.

Explore the full profile